speb/financial-data huggingface dataset:
Financial ratios for API — annual report dated 2024-12-31
Total revenue: 133256000
Gross profit: 85447000
Operating income: -53311000
Net income: -42727000
Capital expenditures: 35155000
Operating cash flow: -14129000
Depreciation & amortization: 10121000
Net tangible assets: 410655000
Owner earnings: -67761000
Return on net tangible assets (%): -16.500712276728642
Buffett classification: The Gruesome
Stock price: 4.16
Shares outstanding: 65504801
Book value: 572661000
P/B ratio: 0.4758486646724677
Market cap (USD): 272499972.16
Debt to equity: 0.08755616324492152
Current ratio: 5.623553612753922
Quick ratio: 5.623553612753922
Interest coverage ratio: -210.71541501976284
COGS to revenue (%): 35.87755898421084
R&D to revenue (%): 60.29296992255509
SG&A to revenue (%): 45.020111664765565
Free cash flow (dilution-adjusted): -72114000
Buyback yield (%): 4.057615093445886
Retained earnings: -486628000
Receivables turnover: 2.6459106884022
Capitalized R&D asset: 170165880
ROCI (R&D-adjusted, %): -7.862664469279245
Rosenberg metric: -0.05186310612108259
FCF margin (%): -54.116887794921055
Revenue growth (%): -5.851432124235187
Rule of 40 score: -59.968319919156244
Financial ratios for API — quarterly report dated 2025-03-31
Total revenue: 33269000
Gross profit: 22634000
Operating income: -3703000
Net income: 407000
Capital expenditures: 10810000
Operating cash flow: 17577000
Depreciation & amortization: 2109000
Net tangible assets: 411772000
Owner earnings: -8294000
Return on net tangible assets (%): -2.0142214623626664
Buffett classification: The Gruesome
Stock price: 4.02
P/E ratio: 161.75018428746927
Shares outstanding: 65504801
Book value: 573028000
P/B ratio: 0.45954002251198894
Market cap (USD): 263329300.01999998
Debt to equity: 0.1053177157137173
Current ratio: 3.5105857377207372
Quick ratio: 3.5105857377207372
Effective tax rate (%): 6.11353711790393
Interest coverage ratio: -740.6
COGS to revenue (%): 31.9666957227449
R&D to revenue (%): 42.135321169857825
SG&A to revenue (%): 37.49135832156061
Free cash flow (dilution-adjusted): 4793000
Buyback yield (%): 0.47127304098167033
Retained earnings: -486221000
Receivables turnover: 1.178372826125456
Capitalized R&D asset: 23929310
ROCI (R&D-adjusted, %): 0.10524654884409237
Rosenberg metric: -0.021226255661461503
FCF margin (%): 14.406805133908444
Revenue growth (%): -11.377197655833777
Rule of 40 score: 3.0296074780746665
Financial ratios for API — quarterly report dated 2025-06-30
Total revenue: 34259000
Gross profit: 22870000
Operating income: -3118000
Net income: 1462000
Capital expenditures: 3785000
Operating cash flow: -352000
Depreciation & amortization: 2043000
Net tangible assets: 404661000
Owner earnings: -280000
Return on net tangible assets (%): -0.0691937201756532
Buffett classification: The Gruesome
Stock price: 3.81
P/E ratio: 123.12446561914159
Shares outstanding: 65504801
Book value: 565377000
P/B ratio: 0.44142809454576326
Market cap (USD): 249573291.81
Debt to equity: 0.11242409931780034
Current ratio: 3.545272836298221
Quick ratio: 3.545272836298221
Effective tax rate (%): 2.9271613342409806
Interest coverage ratio: -3118
COGS to revenue (%): 33.243819142415134
R&D to revenue (%): 40.79511953063429
SG&A to revenue (%): 36.66189906301994
Free cash flow (dilution-adjusted): -5672000
Buyback yield (%): 4.352228526227572
Retained earnings: -484759000
Receivables turnover: 1.287496711638919
Capitalized R&D asset: 28249750
ROCI (R&D-adjusted, %): -0.50372423256099
Rosenberg metric: 0.016835497217862747
FCF margin (%): -16.556233398523016
Revenue growth (%): 2.9757431843457876
Rule of 40 score: -13.580490214177228
Financial ratios for API — quarterly report dated 2025-09-30
Total revenue: 35374000
Gross profit: 23332000
Operating income: -1610000
Net income: 2741000
Capital expenditures: 12705000
Operating cash flow: 731000
Depreciation & amortization: 1989000
Net tangible assets: 405722000
Owner earnings: -7975000
Return on net tangible assets (%): -1.9656316393984057
Buffett classification: The Gruesome
Stock price: 3.82
P/E ratio: 52.480775968959726
Shares outstanding: 65504801
Book value: 566648000
P/B ratio: 0.4415939698366534
Market cap (USD): 250228339.82
Debt to equity: 0.13458443336956982
Current ratio: 4.337264587835752
Quick ratio: 4.337264587835752
Effective tax rate (%): 4.360228198859006
Interest coverage ratio: -100.625
COGS to revenue (%): 34.04195171594957
R&D to revenue (%): 39.059761406682874
SG&A to revenue (%): 32.515406795951826
Free cash flow (dilution-adjusted): -13251000
Buyback yield (%): 1.896667660990758
Retained earnings: -482018000
Receivables turnover: 1.4161495656351335
Capitalized R&D asset: 27806860
ROCI (R&D-adjusted, %): -0.25096983885096086
Rosenberg metric: 0.03305666857469949
FCF margin (%): -37.45971617572228
Revenue growth (%): 3.2546192241454803
Rule of 40 score: -34.2050969515768
Financial ratios for API — annual report dated 2025-12-31
Total revenue: 141057000
Gross profit: 93664000
Operating income: -9410000
Net income: 9528000
Capital expenditures: 31873000
Operating cash flow: 27233000
Depreciation & amortization: 7996000
Net tangible assets: 401161000
Owner earnings: -14349000
Return on net tangible assets (%): -3.576868140223003
Buffett classification: The Gruesome
Stock price: 4.07
P/E ratio: 27.981164994752312
Shares outstanding: 65504801
Book value: 562848000
P/B ratio: 0.47367058259068173
Market cap (USD): 266604540.07000002
Debt to equity: 0.14629171641366764
Current ratio: 4.580434974024831
Quick ratio: 4.580434974024831
Effective tax rate (%): 3.2682383891530913
Interest coverage ratio: -261.3888888888889
COGS to revenue (%): 33.598474375607026
R&D to revenue (%): 39.316730116194165
SG&A to revenue (%): 34.75332666936061
Free cash flow (dilution-adjusted): -10245000
Buyback yield (%): 10.397047249353692
Retained earnings: -477100000
Receivables turnover: 3.8765767994063816
Capitalized R&D asset: 134919260
ROCI (R&D-adjusted, %): -3.141427489308106
Rosenberg metric: 0.10227272727272728
FCF margin (%): -7.263021331802038
Revenue growth (%): 5.854145404334514
Rule of 40 score: -1.4088759274675233
Financial ratios for API — quarterly report dated 2025-12-31
Total revenue: 39885000
Gross profit: 24828000
Operating income: -979000
Net income: 4918000
Capital expenditures: 4574000
Operating cash flow: 9278000
Depreciation & amortization: 1857000
Net tangible assets: 401161000
Owner earnings: 2201000
Return on net tangible assets (%): 0.5486575215437194
Buffett classification: The Gruesome
Stock price: 4.07
P/E ratio: 27.981164994752312
Shares outstanding: 65504801
Book value: 562848000
P/B ratio: 0.47367058259068173
Market cap (USD): 266604540.07000002
Debt to equity: 0.14629171641366764
Current ratio: 4.580434974024831
Quick ratio: 4.580434974024831
Effective tax rate (%): 2.502844141069397
Interest coverage ratio: -69.92857142857143
COGS to revenue (%): 33.413563996489906
R&D to revenue (%): 34.2183778362793
SG&A to revenue (%): 31.30750908862981
Free cash flow (dilution-adjusted): 3885000
Buyback yield (%): 4.076824797186958
Retained earnings: -477100000
Receivables turnover: 1.0961332343969
Capitalized R&D asset: 27517470
ROCI (R&D-adjusted, %): -0.1654545530671893
Rosenberg metric: 0.10827241803575306
FCF margin (%): 9.740503948852952
Revenue growth (%): 12.752303952055183
Rule of 40 score: 22.492807900908133
Financial ratios for ARBN.SW — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.76923076923077
Shares outstanding: 69472251
Market cap (USD): 748162703.0769231
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARBN.SW — annual report dated 2022-12-31
Total revenue: 604245652.173913
Gross profit: 356922826.0869565
Operating income: 13503260.869565217
Net income: 20790217.391304348
Capital expenditures: 170429347.82608694
Operating cash flow: -27998913.043478258
Depreciation & amortization: 77489130.43478261
Net tangible assets: 672655434.7826086
Owner earnings: -72149999.99999999
Return on net tangible assets (%): -10.726145403599944
Capex to operating income (%): 1262.134750060372
Buffett classification: The Gruesome
Stock price: 6.7934782608695645
P/E ratio: 22.700976041721123
Shares outstanding: 69472251
Book value: 1073415217.3913043
P/B ratio: 0.4396790908639835
Market cap (USD): 471958226.9021739
Debt to equity: 0.21625004303614428
Current ratio: 1.2535226302305722
Quick ratio: 0.5818507448524527
Effective tax rate (%): 90.38795599305153
Interest coverage ratio: 4.032132424537488
COGS to revenue (%): 40.930840825607206
Free cash flow (dilution-adjusted): -216535869.5652174
Buyback yield (%): 2.9244482088251327
Retained earnings: 383403260.8695652
Inventory turnover: 1.0044896697863324
Receivables turnover: 5.074033169342545
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.0507805363269118
FCF margin (%): -35.83573481847651
Rule of 40 score: -35.83573481847651
Financial ratios for ARBN.SW — annual report dated 2023-12-31
Total revenue: 600720238.0952381
Gross profit: 364157142.85714287
Operating income: -12508333.333333334
Net income: -20490476.19047619
Capital expenditures: 91745238.0952381
Operating cash flow: 120230952.38095239
Depreciation & amortization: 92634523.8095238
Net tangible assets: 795663095.2380953
Owner earnings: -19601190.476190493
Return on net tangible assets (%): -2.463503786150218
Buffett classification: The Gruesome
Stock price: 5.7023809523809526
Shares outstanding: 69472251
Book value: 1096394047.6190476
P/B ratio: 0.36132742756286573
Market cap (USD): 396157240.8214286
Debt to equity: 0.23625391027513354
Current ratio: 1.783027690712199
Quick ratio: 1.655032801988953
Interest coverage ratio: -1.2694212879062463
COGS to revenue (%): 39.37991101951031
Free cash flow (dilution-adjusted): 9598809.523809524
Buyback yield (%): 0.817977271791648
Retained earnings: 406102380.95238096
Inventory turnover: 3.5938833827678507
Receivables turnover: 10.083831258368138
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.0001027991836984
FCF margin (%): 1.5978834930292012
Revenue growth (%): -0.583440537137739
Rule of 40 score: 1.0144429558914623
Financial ratios for ARBN.SW — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 659335555.5555556
Buffett classification: The Gruesome
Stock price: 6.177777777777777
Shares outstanding: 69472251
Book value: 1051575555.5555556
P/B ratio: 0.4081343714510924
Market cap (USD): 429184128.4
Debt to equity: 0.3956951368211509
Current ratio: 1.2531962521573756
Quick ratio: 1.1383010346302358
Buyback yield (%): 0
Retained earnings: 393498888.8888889
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARBN.SW — annual report dated 2024-12-31
Total revenue: 618120000
Gross profit: 383245555.5555555
Operating income: 18748888.888888888
Net income: 9198888.888888888
Capital expenditures: 61051111.11111111
Operating cash flow: 45935555.55555555
Depreciation & amortization: 80130000
Net tangible assets: 659335555.5555556
Owner earnings: 28277777.777777784
Return on net tangible assets (%): 4.288829495013499
Capex to operating income (%): 325.62522223539173
Buffett classification: The Gruesome
Stock price: 6.177777777777777
P/E ratio: 46.65608353182751
Shares outstanding: 69472251
Book value: 1051575555.5555556
P/B ratio: 0.4081343714510924
Market cap (USD): 429184128.4
Debt to equity: 0.3956951368211509
Current ratio: 1.2531962521573756
Quick ratio: 1.1383010346302358
Effective tax rate (%): 66.27393225331369
Interest coverage ratio: 1.4017278617710582
COGS to revenue (%): 37.998195244361035
Free cash flow (dilution-adjusted): -38346666.66666667
Buyback yield (%): 0.2783058285257048
Retained earnings: 393498888.8888889
Inventory turnover: 2.7902927743604637
Receivables turnover: 12.074752561208543
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.6212295172533062
FCF margin (%): -6.203757630665028
Revenue growth (%): 2.8964833879965526
Rule of 40 score: -3.3072742426684756
Financial ratios for ARBN.SW — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 502603750
Buffett classification: The Gruesome
Stock price: 6.637499999999999
Shares outstanding: 69472251
Market cap (USD): 461122066.0124999
Current ratio: 0.8980292533345294
Quick ratio: 0.8980292533345294
Buyback yield (%): 0
Retained earnings: 556965000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARGX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 350.19
Shares outstanding: 62560993
Market cap (USD): 21908234138.67
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARGX — annual report dated 2022-12-31
Total revenue: 436963829.78723407
Gross profit: 405654255.31914896
Operating income: -770126595.7446809
Net income: -754887234.0425532
Capital expenditures: 890425.5319148937
Operating cash flow: -917879787.2340426
Depreciation & amortization: 111002127.65957448
Net tangible assets: 2807231914.893617
Owner earnings: -644775531.9148936
Return on net tangible assets (%): -22.96837423705793
Buffett classification: The Gruesome
Stock price: 378.83
Shares outstanding: 62560993
Book value: 2993296808.5106387
P/B ratio: 7.91768491210275
Market cap (USD): 23699980978.19
Debt to equity: 0.004416250636617491
Current ratio: 9.177664857068185
Quick ratio: 8.422222001673962
Interest coverage ratio: -330.10442316461473
COGS to revenue (%): 7.165255413321127
R&D to revenue (%): 161.50272918056413
SG&A to revenue (%): 114.40671363811212
Free cash flow (dilution-adjusted): -1195378723.4042554
Buyback yield (%): 0
Retained earnings: -2244458510.638298
Inventory turnover: 0.12888378957140917
Receivables turnover: 1.481366874042016
Capitalized R&D asset: 705708510.6382979
ROCI (R&D-adjusted, %): -8.058563520105281
FCF margin (%): -273.56468474434325
Rule of 40 score: -273.56468474434325
Financial ratios for ARGX — annual report dated 2023-12-31
Total revenue: 1362573333.3333333
Gross profit: 1231645555.5555556
Operating income: -467375555.5555555
Net income: -327836666.6666667
Capital expenditures: 902222.2222222222
Operating cash flow: -467030000
Depreciation & amortization: 123674444.44444445
Net tangible assets: 4413643333.333333
Owner earnings: -205064444.44444445
Return on net tangible assets (%): -4.646148973926555
Buffett classification: The Gruesome
Stock price: 380.43
Shares outstanding: 62560993
Book value: 4552785555.555555
P/B ratio: 5.227586117678627
Market cap (USD): 23800078566.99
Debt to equity: 0.004881016676725628
Current ratio: 9.748948564160637
Quick ratio: 9.014775658226023
Interest coverage ratio: -464.280353200883
COGS to revenue (%): 9.608861011354334
R&D to revenue (%): 70.08731843994534
SG&A to revenue (%): 57.85939350053331
Free cash flow (dilution-adjusted): -774570000
Buyback yield (%): 0
Retained earnings: -2672048888.888889
Inventory turnover: 0.37943970375140884
Receivables turnover: 2.456213158785509
Capitalized R&D asset: 1427815813.2387707
ROCI (R&D-adjusted, %): -1.0982680166612226
Rosenberg metric: 1.1704425946192933
FCF margin (%): -56.84611470452967
Revenue growth (%): 211.8274878716611
Rule of 40 score: 154.98137316713144
Financial ratios for ARGX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 542.08
Shares outstanding: 62560993
Market cap (USD): 33913063085.440002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARGX — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 5538372916.666667
Buffett classification: The Gruesome
Stock price: 615
Shares outstanding: 62560993
Book value: 5727378125
P/B ratio: 6.71773538524663
Market cap (USD): 38475010695
Debt to equity: 0.007102762807952956
Current ratio: 7.289127293571133
Quick ratio: 6.681240633154006
Buyback yield (%): 0
Retained earnings: -1637295833.3333335
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARGX — annual report dated 2024-12-31
Total revenue: 2281490625
Gross profit: 2044731250
Operating income: -18587500
Net income: 867750000
Capital expenditures: 1876041.6666666667
Operating cash flow: -86194791.66666667
Depreciation & amortization: 18257291.666666668
Net tangible assets: 5538372916.666667
Owner earnings: 884131250
Return on net tangible assets (%): 15.96373634103578
Buffett classification: The Gruesome
Stock price: 615
P/E ratio: 44.33881958513396
Shares outstanding: 62560993
Book value: 5727378125
P/B ratio: 6.71773538524663
Market cap (USD): 38475010695
Debt to equity: 0.007102762807952956
Current ratio: 7.289127293571133
Quick ratio: 6.681240633154006
Effective tax rate (%): -877.9760507161307
Interest coverage ratio: -7.241883116883116
COGS to revenue (%): 10.377398548372295
R&D to revenue (%): 44.900423745257925
SG&A to revenue (%): 48.04004691742561
Free cash flow (dilution-adjusted): -402319791.6666667
Buyback yield (%): 0
Retained earnings: -1637295833.3333335
Inventory turnover: 0.5581301122453239
Receivables turnover: 2.4092406082525937
Capitalized R&D asset: 1897126811.288416
ROCI (R&D-adjusted, %): 1.4461470804172916
Rosenberg metric: 0.851406557594486
FCF margin (%): -17.63407604038113
Revenue growth (%): 67.43984115839638
Rule of 40 score: 49.805765118015245
Financial ratios for ARGX — quarterly report dated 2025-03-31
Total revenue: 858695652.173913
Gross profit: 770652173.9130435
Operating income: 151086956.52173913
Net income: 183695652.17391303
Capital expenditures: 0
Owner earnings: 183695652.17391303
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 591.86
P/E ratio: 50.3922505497361
Shares outstanding: 62560993
Market cap (USD): 37027349316.98
Effective tax rate (%): 16.33663366336634
Interest coverage ratio: 139
COGS to revenue (%): 10.253164556962027
R&D to revenue (%): 39.36708860759494
SG&A to revenue (%): 34.936708860759495
Buyback yield (%): 0
Capitalized R&D asset: 338043478.26086956
ROCI (R&D-adjusted, %): 111.36120042872453
Rule of 40 score: 0
Financial ratios for ARGX — quarterly report dated 2025-06-30
Total revenue: 1115248235.2941177
Gross profit: 984957647.0588236
Operating income: 239812941.1764706
Net income: 288656470.5882353
Capital expenditures: 0
Net tangible assets: 6913852941.176471
Owner earnings: 288656470.5882353
Return on net tangible assets (%): 4.175044986408362
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 551.22
P/E ratio: 73.00670177960598
Shares outstanding: 62560993
Book value: 7171472941.176471
P/B ratio: 4.808617538449891
Market cap (USD): 34484870561.46
Debt to equity: 0.0070790281494391505
Current ratio: 5.595274612632259
Quick ratio: 5.2683529384665
Effective tax rate (%): 14.479311534721278
Interest coverage ratio: 181.03108348134992
COGS to revenue (%): 11.682653611277257
R&D to revenue (%): 34.568616219443626
SG&A to revenue (%): 33.899495865336235
Buyback yield (%): 0
Retained earnings: -1361149411.764706
Inventory turnover: 0.325132625410647
Receivables turnover: 0.7911370642933804
Capitalized R&D asset: 612015012.7877238
ROCI (R&D-adjusted, %): 4.907297131325838
Rosenberg metric: 0.6339583128428221
Revenue growth (%): 29.87700967982131
Rule of 40 score: 29.87700967982131
Financial ratios for ARGX — quarterly report dated 2025-09-30
Total revenue: 1325836470.5882354
Gross profit: 1197100000
Operating income: 411729411.7647059
Net income: 405009411.7647059
Capital expenditures: 0
Owner earnings: 405009411.7647059
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 737.56
P/E ratio: 52.59232845438549
Shares outstanding: 62560993
Market cap (USD): 46142485997.079994
Effective tax rate (%): 10.826233703662451
Interest coverage ratio: 352.4370594159114
COGS to revenue (%): 9.709830242572725
R&D to revenue (%): 31.55841240291367
SG&A to revenue (%): 29.840517994855194
Buyback yield (%): 0
Capitalized R&D asset: 788269630.1790283
ROCI (R&D-adjusted, %): 57.021299371341385
Rosenberg metric: 0.5502674726958133
Revenue growth (%): 18.88263335727947
Rule of 40 score: 18.88263335727947
Financial ratios for ARGX — quarterly report dated 2025-12-31
Total revenue: 1515149411.764706
Gross profit: 1339047058.8235295
Operating income: 423008235.2941176
Net income: 627000000
Capital expenditures: 0
Net tangible assets: 8295281176.470589
Owner earnings: 627000000
Return on net tangible assets (%): 7.558514131847319
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 840.95
P/E ratio: 34.97209005672755
Shares outstanding: 62560993
Book value: 8615402352.941175
P/B ratio: 6.106582711762669
Market cap (USD): 52610667063.350006
Debt to equity: 0.006439902707763334
Current ratio: 5.225857568554734
Quick ratio: 4.8671732619494525
Effective tax rate (%): -32.14925091868463
Interest coverage ratio: 434.24758454106274
COGS to revenue (%): 11.622771429259162
R&D to revenue (%): 28.862538891524576
SG&A to revenue (%): 32.80880084045293
Buyback yield (%): 0
Retained earnings: -329140000
Inventory turnover: 0.31610879986484486
Receivables turnover: 0.7772064845005519
Capitalized R&D asset: 844870800.0000001
ROCI (R&D-adjusted, %): 4.697438501389213
Rosenberg metric: 0.3392511197775349
Revenue growth (%): 14.27875498797207
Rule of 40 score: 14.27875498797207
Financial ratios for ARGX — annual report dated 2025-12-31
Total revenue: 4886449411.764706
Gross profit: 4356255294.117647
Operating income: 1240723529.4117646
Net income: 1520041176.4705882
Capital expenditures: 7252941.176470588
Operating cash flow: 806108235.2941177
Depreciation & amortization: 33061176.470588237
Net tangible assets: 8295281176.470589
Owner earnings: 1545849411.764706
Return on net tangible assets (%): 18.63528648250621
Capex to operating income (%): 0.5845735173499335
Buffett classification: The Great
Stock price: 840.95
P/E ratio: 34.611343348939855
Shares outstanding: 62560993
Book value: 8615402352.941175
P/B ratio: 6.106582711762669
Market cap (USD): 52610667063.350006
Debt to equity: 0.006439902707763334
Current ratio: 5.225857568554734
Quick ratio: 4.8671732619494525
Effective tax rate (%): -1.0502054188660002
Interest coverage ratio: 258.35742283194514
COGS to revenue (%): 10.850293801682541
R&D to revenue (%): 32.843094059394026
SG&A to revenue (%): 32.74308158793032
Free cash flow (dilution-adjusted): 382862352.9411765
Buyback yield (%): 0
Retained earnings: -329140000
Inventory turnover: 0.9517137245792241
Receivables turnover: 2.506538391209969
Capitalized R&D asset: 2606355545.220588
ROCI (R&D-adjusted, %): 14.650466852397614
Rosenberg metric: 2.2564685617002462
FCF margin (%): 7.835185032702682
Revenue growth (%): 114.1779307887669
Rule of 40 score: 122.01311582146958
Financial ratios for ARL.V — annual report dated 2022-12-31
Total revenue: 0
Operating income: -325833.0882352941
Net income: -326099.26470588235
Capital expenditures: 0
Operating cash flow: -161263.97058823527
Net tangible assets: 433395.5882352941
Owner earnings: -326099.26470588235
Return on net tangible assets (%): -75.2428666922286
Buffett classification: The Gruesome
Stock price: 0.08088235294117646
Shares outstanding: 22982500
Book value: 433395.58823529404
P/B ratio: 4.2891038278437374
Market cap (USD): 1858878.676470588
Debt to equity: 0
Current ratio: 5.179674826586413
Quick ratio: 5.179674826586413
Free cash flow (dilution-adjusted): -270784.5588235294
Buyback yield (%): 3.955578849519892e-05
Retained earnings: -340190.44117647054
Capitalized R&D asset: 121193.38235294117
ROCI (R&D-adjusted, %): -44.18362300643959
Rule of 40 score: 0
Financial ratios for ARL.V — annual report dated 2023-12-31
Total revenue: 0
Operating income: -350863.63636363635
Net income: -337105.30303030304
Capital expenditures: 0
Operating cash flow: -358475
Net tangible assets: 1622275.7575757576
Owner earnings: -337105.30303030304
Return on net tangible assets (%): -20.779778126873772
Buffett classification: The Gruesome
Stock price: 0.08333333333333333
Shares outstanding: 22982500
Book value: 1622275.7575757573
P/B ratio: 1.1805689164678874
Market cap (USD): 1915208.3333333333
Debt to equity: 0
Current ratio: 8.620538423246165
Quick ratio: 8.620538423246165
Free cash flow (dilution-adjusted): -358475
Buyback yield (%): 0
Retained earnings: -687604.5454545454
Receivables turnover: 0
Capitalized R&D asset: 215485.17223707662
ROCI (R&D-adjusted, %): -16.418767436647837
Rule of 40 score: 0
Financial ratios for ARL.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.08888888888888888
Shares outstanding: 22982500
Market cap (USD): 2042888.8888888888
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARL.V — annual report dated 2024-12-31
Total revenue: 0
Operating income: -795890.9090909092
Net income: -768481.8181818182
Capital expenditures: 196722.37762237762
Operating cash flow: -915988.8111888112
Net tangible assets: 773933.5664335665
Owner earnings: -965204.1958041958
Return on net tangible assets (%): -124.71408886579773
Buffett classification: The Gruesome
Stock price: 0.06293706293706294
Shares outstanding: 22982500
Book value: 773933.5664335665
P/B ratio: 1.8689602204703066
Market cap (USD): 1446451.048951049
Debt to equity: 0
Current ratio: 23.74753239190566
Quick ratio: 23.74753239190566
Free cash flow (dilution-adjusted): -1112711.1888111888
Buyback yield (%): 0
Retained earnings: -1403193.7062937063
Receivables turnover: 0
Capitalized R&D asset: 129965.17223707665
ROCI (R&D-adjusted, %): -97.47226477947952
Rule of 40 score: 0
Financial ratios for ARL.V — quarterly report dated 2024-12-31
Total revenue: 0
Operating income: -89406.99300699301
Net income: -86251.04895104896
Capital expenditures: 67613.28671328671
Operating cash flow: -115197.2027972028
Net tangible assets: 773933.5664335665
Owner earnings: -153864.33566433567
Return on net tangible assets (%): -19.880819535114863
Buffett classification: The Gruesome
Stock price: 0.06293706293706294
Shares outstanding: 22982500
Book value: 773933.5664335665
P/B ratio: 1.8689602204703066
Market cap (USD): 1446451.048951049
Debt to equity: 0
Current ratio: 23.74753239190566
Quick ratio: 23.74753239190566
Free cash flow (dilution-adjusted): -182810.4895104895
Buyback yield (%): 0
Retained earnings: -1403193.7062937063
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -11.552282635704444
Rule of 40 score: 0
Financial ratios for ARL.V — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -115750.34965034966
Net income: -113490.20979020979
Capital expenditures: 26223.776223776225
Operating cash flow: -30067.83216783217
Net tangible assets: 681422.3776223777
Owner earnings: -139713.98601398602
Return on net tangible assets (%): -20.503287036371884
Buffett classification: The Gruesome
Stock price: 0.06993006993006994
Shares outstanding: 22982500
Book value: 681422.3776223776
P/B ratio: 2.3585486549114667
Market cap (USD): 1607167.8321678322
Debt to equity: 0
Current ratio: 11.920090895432692
Quick ratio: 11.920090895432692
Free cash flow (dilution-adjusted): -56291.608391608395
Buyback yield (%): 0
Retained earnings: -1516683.916083916
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -16.986578875531848
Rule of 40 score: 0
Financial ratios for ARL.V — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -100082.48175182482
Net income: -97514.59854014598
Capital expenditures: 0
Operating cash flow: -140825.54744525548
Net tangible assets: 613751.0948905109
Owner earnings: -97514.59854014598
Return on net tangible assets (%): -15.888297284022268
Buffett classification: The Gruesome
Stock price: 0.0656934306569343
Shares outstanding: 22982500
Book value: 613751.0948905109
P/B ratio: 2.459953689112898
Market cap (USD): 1509799.2700729924
Debt to equity: 0
Current ratio: 15.612182310528203
Quick ratio: 15.612182310528203
Free cash flow (dilution-adjusted): -140825.54744525548
Buyback yield (%): 0
Retained earnings: -1680622.6277372262
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -16.306688914286802
Rule of 40 score: 0
Financial ratios for ARL.V — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -99331.654676259
Net income: -97844.60431654677
Capital expenditures: 26978.41726618705
Operating cash flow: -102623.74100719426
Net tangible assets: 525420.8633093525
Owner earnings: -124823.02158273383
Return on net tangible assets (%): -23.75676915388144
Buffett classification: The Gruesome
Stock price: 0.05035971223021583
Shares outstanding: 22982500
Book value: 525420.8633093525
P/B ratio: 2.2027905002498853
Market cap (USD): 1157392.0863309354
Debt to equity: 0
Current ratio: 10.44228783811687
Quick ratio: 10.44228783811687
Free cash flow (dilution-adjusted): -129602.1582733813
Buyback yield (%): 0
Retained earnings: -1754285.6115107916
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -18.90515996083989
Rule of 40 score: 0
Financial ratios for AZJ.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.150375939849624
Shares outstanding: 1683307283
Market cap (USD): 3619743480.7368417
Buyback yield (%): 6.231488805071896
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AZJ.AX — annual report dated 2022-06-30
Total revenue: 2066000000
Gross profit: 1767310344.8275862
Operating income: 548896551.7241379
Net income: 353793103.44827586
Capital expenditures: 342000000
Depreciation & amortization: 408482758.6206897
Net tangible assets: 2892827586.206897
Owner earnings: 420275862.06896555
Return on net tangible assets (%): 14.528202927573547
Capex to operating income (%): 62.30682246513381
Buffett classification: The Good
Stock price: 2.151724137931035
P/E ratio: 10.237658329356726
Shares outstanding: 1683307283
Book value: 3042965517.2413793
P/B ratio: 1.1902904886249803
Market cap (USD): 3622012912.3862076
Debt to equity: 0.7578587131428054
Current ratio: 0.8897393462970624
Quick ratio: 0.6884567645841952
Effective tax rate (%): 30.308382013313405
Interest coverage ratio: 6.518427518427519
COGS to revenue (%): 14.457388924124581
SG&A to revenue (%): 28.06355776613146
Free cash flow (dilution-adjusted): 531724137.9310345
Buyback yield (%): 0
Retained earnings: 491172413.79310346
Inventory turnover: 2.2255909558067835
Receivables turnover: 6.900944482838056
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.139136725343622
FCF margin (%): 25.736889541676405
Rule of 40 score: 25.736889541676405
Financial ratios for AZJ.AX — annual report dated 2023-06-30
Total revenue: 2276821192.05298
Gross profit: 1919867549.6688743
Operating income: 435099337.74834436
Net income: 182781456.95364237
Capital expenditures: 488079470.1986755
Depreciation & amortization: 441059602.6490066
Net tangible assets: 2737086092.715232
Owner earnings: 135761589.40397346
Return on net tangible assets (%): 4.960077425598836
Capex to operating income (%): 112.1765601217656
Buffett classification: The Gruesome
Stock price: 2.23841059602649
P/E ratio: 20.61441527731884
Shares outstanding: 1683307283
Book value: 2600000000
P/B ratio: 1.449204945629139
Market cap (USD): 3767932858.6357613
Debt to equity: 1.423586347427407
Current ratio: 0.6868163500287853
Quick ratio: 0.5451928612550374
Effective tax rate (%): 32.91925465838509
Interest coverage ratio: 2.8942731277533036
COGS to revenue (%): 15.677719604421178
SG&A to revenue (%): 28.272251308900525
Free cash flow (dilution-adjusted): 201986754.9668874
Buyback yield (%): 0
Retained earnings: 436423841.0596026
Inventory turnover: 2.1910569105691056
Receivables turnover: 4.722527472527472
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.608328304164153
FCF margin (%): 8.871436881908085
Revenue growth (%): 10.204317137123908
Rule of 40 score: 19.075754019031994
Financial ratios for AZJ.AX — annual report dated 2024-06-30
Total revenue: 2504000000
Gross profit: 2116000000
Operating income: 556000000
Net income: 270666666.6666667
Capital expenditures: 530000000
Depreciation & amortization: 471333333.3333333
Net tangible assets: 2819333333.3333335
Owner earnings: 212000000
Return on net tangible assets (%): 7.519508157956964
Capex to operating income (%): 95.32374100719424
Buffett classification: The Gruesome
Stock price: 2.1999999999999997
P/E ratio: 13.682054270689653
Shares outstanding: 1683307283
Book value: 2958666666.666667
P/B ratio: 1.251670579968454
Market cap (USD): 3703276022.5999994
Debt to equity: 1.1090581342947272
Current ratio: 0.5741599073001158
Quick ratio: 0.4241019698725376
Effective tax rate (%): 30.479452054794525
Interest coverage ratio: 2.512048192771084
COGS to revenue (%): 15.495207667731629
SG&A to revenue (%): 28.780617678381255
Free cash flow (dilution-adjusted): 528666666.6666667
Buyback yield (%): 0
Retained earnings: 492666666.6666667
Inventory turnover: 2.247104247104247
Receivables turnover: 6.554973821989528
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.44984802431611
FCF margin (%): 21.112886048988287
Revenue growth (%): 9.977894124490993
Rule of 40 score: 31.09078017347928
Financial ratios for BBGI — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 38
Shares outstanding: 976753
Market cap (USD): 37116614
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BBGI — annual report dated 2022-12-31
Total revenue: 256381018
Operating income: 15223050
Net income: -42057430
Capital expenditures: 13363000
Operating cash flow: 11147084
Depreciation & amortization: 9920546
Net tangible assets: -285246389
Owner earnings: -45499884
Capex to operating income (%): 87.78135787506446
Buffett classification: The Gruesome
Stock price: 18.4
Shares outstanding: 976753
Book value: 223488808
P/B ratio: 0.08041680190088087
Market cap (USD): 17972255.2
Debt to equity: 1.4816138041239184
Current ratio: 1.863677424913764
Quick ratio: 1.863677424913764
Interest coverage ratio: 0.565617319878896
COGS to revenue (%): 0
SG&A to revenue (%): 7.021330650929859
Free cash flow (dilution-adjusted): -3274819
Buyback yield (%): 0.7452598380641735
Retained earnings: 100163064
Receivables turnover: 4.523025226059508
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.3126592986410865
FCF margin (%): -1.2773250631214828
Rule of 40 score: -1.2773250631214828
Financial ratios for BBGI — annual report dated 2023-12-31
Total revenue: 247109258
Operating income: 17805963
Net income: -75120138
Capital expenditures: 4189554
Operating cash flow: -4678549
Depreciation & amortization: 8809343
Net tangible assets: -247672673
Owner earnings: -70500349
Capex to operating income (%): 23.52893803047889
Buffett classification: The Great
Stock price: 17.6
Shares outstanding: 976753
Book value: 148978635
P/B ratio: 0.11539139689392378
Market cap (USD): 17190852.8
Debt to equity: 2.0521481956120757
Current ratio: 1.794083181795142
Quick ratio: 1.794083181795142
Interest coverage ratio: 0.669197855375392
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): -9714478
Buyback yield (%): 0.48792809161858447
Retained earnings: 25042926
Receivables turnover: 4.625418377845125
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.3853437491003566
FCF margin (%): -3.9312480959333382
Revenue growth (%): -3.616398777229288
Rule of 40 score: -7.547646873162626
Financial ratios for BBGI — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.77
Shares outstanding: 976753
Market cap (USD): 10519629.809999999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BBGI — annual report dated 2024-12-31
Total revenue: 240291611
Operating income: 14014098
Net income: -5887258
Capital expenditures: 3013668
Operating cash flow: -3711785
Depreciation & amortization: 7236060
Net tangible assets: -247122222
Owner earnings: -1664866
Capex to operating income (%): 21.504544923262277
Buffett classification: The Great
Stock price: 9.41
Shares outstanding: 976753
Book value: 147219707
P/B ratio: 0.06243216969586823
Market cap (USD): 9191245.73
Debt to equity: 1.9508870167769048
Current ratio: 1.3076777061887457
Quick ratio: 1.3076777061887457
Interest coverage ratio: 0.6600141374096119
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): -7618745
Buyback yield (%): 1.0738587880187163
Retained earnings: 19155668
Receivables turnover: 4.661155093178347
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.82417227412623
FCF margin (%): -3.1706246290886955
Revenue growth (%): -2.7589605728167417
Rule of 40 score: -5.929585201905438
Financial ratios for BBGI — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.41
Shares outstanding: 976753
Market cap (USD): 9191245.73
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BBGI — quarterly report dated 2025-03-31
Total revenue: 48912465
Operating income: -2000589
Net income: -2689821
Capital expenditures: 800165
Operating cash flow: -3474505
Depreciation & amortization: 1652331
Net tangible assets: -249665714
Owner earnings: -1837655
Buffett classification: The Gruesome
Stock price: 5.55
Shares outstanding: 976753
Book value: 144619400
P/B ratio: 0.03748445333060433
Market cap (USD): 5420979.149999999
Debt to equity: 1.9637991375984134
Current ratio: 1.149335430286193
Quick ratio: 1.149335430286193
Interest coverage ratio: -0.5917778339143867
COGS to revenue (%): 0
SG&A to revenue (%): 0.20162345120001618
Free cash flow (dilution-adjusted): -4373289
Buyback yield (%): 0.16795858733380298
Retained earnings: 16465847
Receivables turnover: 1.0563071445567376
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.4127076243711352
FCF margin (%): -8.941052142843342
Rule of 40 score: -8.941052142843342
Financial ratios for BBGI — quarterly report dated 2025-06-30
Total revenue: 52999711
Operating income: 2891256
Net income: -154175
Capital expenditures: 573173
Operating cash flow: 3054582
Depreciation & amortization: 1589014
Net tangible assets: -242518782
Owner earnings: 861666
Capex to operating income (%): 19.82436007050223
Buffett classification: The Great
Stock price: 4.15
Shares outstanding: 976753
Book value: 144523897
P/B ratio: 0.028047437372934945
Market cap (USD): 4053524.95
Debt to equity: 1.9389017928294585
Current ratio: 1.1128757079531257
Quick ratio: 1.1128757079531257
Effective tax rate (%): 143.88638655121574
Interest coverage ratio: 0.8775283995372062
COGS to revenue (%): 0
SG&A to revenue (%): 0.14454607120404864
Free cash flow (dilution-adjusted): 2404800
Buyback yield (%): 0.442503752197208
Retained earnings: 16311672
Receivables turnover: 1.0335347989651724
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.5990051680660197
FCF margin (%): 4.537383232146303
Revenue growth (%): 8.356246204316221
Rule of 40 score: 12.893629436462525
Financial ratios for BBGI — quarterly report dated 2025-09-30
Total revenue: 50977046
Operating income: -536676
Net income: -3556703
Capital expenditures: 2221503
Operating cash flow: -4892488
Depreciation & amortization: 1530090
Net tangible assets: -239953150
Owner earnings: -4248116
Buffett classification: The Gruesome
Stock price: 5.27
Shares outstanding: 976753
Book value: 141019373
P/B ratio: 0.0365019940203535
Market cap (USD): 5147488.31
Debt to equity: 1.9525628439717995
Current ratio: 1.1501815493586807
Quick ratio: 1.1501815493586807
Interest coverage ratio: -0.16366908394583643
COGS to revenue (%): 0
SG&A to revenue (%): 0.10235783375913937
Free cash flow (dilution-adjusted): -7166170
Buyback yield (%): 0
Retained earnings: 12754969
Receivables turnover: 1.0657816249980374
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.11317461182171616
FCF margin (%): -14.057640766395135
Revenue growth (%): -3.8163698666205934
Rule of 40 score: -17.87401063301573
Financial ratios for BBGI — annual report dated 2025-12-31
Total revenue: 205939627
Operating income: -4858915
Net income: -196549741
Capital expenditures: 4835724
Operating cash flow: -8468895
Depreciation & amortization: 6331852
Net tangible assets: -205454532
Owner earnings: -195053613
Buffett classification: The Gruesome
Stock price: 5.01
Shares outstanding: 976753
Book value: -49330431
Market cap (USD): 4893532.529999999
Debt to equity: -5.487292377396824
Current ratio: 1.003821170572019
Quick ratio: 1.003821170572019
Interest coverage ratio: -0.367159470446886
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): -13507421
Buyback yield (%): 0.6034699844940032
Retained earnings: -177394073
Receivables turnover: 4.529265266905485
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.032532228330374
FCF margin (%): -6.558922727387478
Revenue growth (%): -14.29595642437971
Rule of 40 score: -20.85487915176719
Financial ratios for BBGI — quarterly report dated 2025-12-31
Total revenue: 53050405
Operating income: -5212906
Net income: -190149042
Capital expenditures: 1240883
Operating cash flow: -3156484
Depreciation & amortization: 1560417
Net tangible assets: -205454532
Owner earnings: -189829508
Buffett classification: The Gruesome
Stock price: 5.01
Shares outstanding: 976753
Book value: -49330431
Market cap (USD): 4893532.529999999
Debt to equity: -5.487292377396824
Current ratio: 1.003821170572019
Quick ratio: 1.003821170572019
Interest coverage ratio: -1.58961320137649
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): -4372762
Buyback yield (%): 0.050863052094598016
Retained earnings: -177394073
Receivables turnover: 1.166746586181634
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.180610166725859
FCF margin (%): -8.242655263423531
Revenue growth (%): 4.067240381092306
Rule of 40 score: -4.175414882331225
Financial ratios for BCHT — annual report dated 2021-12-31
Capital expenditures: 10975
Buffett classification: The Gruesome
Stock price: 2.95
Shares outstanding: 26305966
Market cap (USD): 77602599.7
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BCHT — annual report dated 2022-12-31
Total revenue: 21620153
Gross profit: 7021408
Operating income: 903987
Net income: -1581476
Capital expenditures: 10727
Operating cash flow: 70989
Depreciation & amortization: 554814
Net tangible assets: -9326456
Owner earnings: -1037389
Capex to operating income (%): 1.1866321086475802
Buffett classification: The Great
Stock price: 1.3
Shares outstanding: 26305966
Book value: -7416859
Market cap (USD): 34197755.800000004
Debt to equity: -1.3398621977308722
Current ratio: 1.7181662699735625
Quick ratio: 1.4107983222595226
Interest coverage ratio: 0.5756243767694018
COGS to revenue (%): 67.52378209349398
SG&A to revenue (%): 28.29499402710055
Free cash flow (dilution-adjusted): -611418
Buyback yield (%): 0
Retained earnings: -68698389
Inventory turnover: 14.72937987006763
Receivables turnover: 7.7837336239432
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.781395710848196
FCF margin (%): -2.8280003383879846
Rule of 40 score: -2.8280003383879846
Financial ratios for BCHT — annual report dated 2023-12-31
Total revenue: 17625370
Gross profit: 5452996
Operating income: -8753765
Net income: 5668314
Capital expenditures: 0
Operating cash flow: 19226037
Depreciation & amortization: 259385
Net tangible assets: -1643709
Owner earnings: 5927699
Return on net tangible assets (%): -360.62946665133546
Buffett classification: The Gruesome
Stock price: 4.6
P/E ratio: 21.348048749592913
Shares outstanding: 26305966
Book value: 60354
P/B ratio: 2004.96145408755
Market cap (USD): 121007443.6
Debt to equity: 186.0745932332571
Current ratio: 11.447934929768925
Quick ratio: 11.083742793230996
Effective tax rate (%): 7.7051358725606836
Interest coverage ratio: -6.4252485134699695
COGS to revenue (%): 69.0616650884492
SG&A to revenue (%): 80.60404405694746
Free cash flow (dilution-adjusted): 18705588
Buyback yield (%): 0
Retained earnings: -61951125
Inventory turnover: 15.308004386516492
Receivables turnover: 5.729103756197866
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -33.50405396923086
FCF margin (%): 106.1287677932435
Revenue growth (%): -18.477126410715037
Rule of 40 score: 87.65164138252845
Financial ratios for BCHT — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.75
Shares outstanding: 26305966
Market cap (USD): 98647372.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BCHT — quarterly report dated 2024-12-31
Capital expenditures: 107408
Buffett classification: The Gruesome
Stock price: 2.55
Shares outstanding: 26305966
Market cap (USD): 67080213.3
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BCHT — annual report dated 2024-12-31
Total revenue: 17406185
Gross profit: 7101109
Operating income: -7115268
Net income: -10802111
Capital expenditures: 809432
Operating cash flow: -4105167
Depreciation & amortization: 248084
Net tangible assets: -307602
Owner earnings: -11363459
Buffett classification: The Gruesome
Stock price: 2.55
Shares outstanding: 26305966
Book value: 1191861
P/B ratio: 56.28190980324048
Market cap (USD): 67080213.3
Debt to equity: 0.2569284505491832
Current ratio: 0.6926416915809218
Quick ratio: 0.6220282177715794
Interest coverage ratio: -26.603309678528966
COGS to revenue (%): 59.20353023939479
R&D to revenue (%): 0
SG&A to revenue (%): 81.67428416967877
Free cash flow (dilution-adjusted): -6003522
Buyback yield (%): 0
Retained earnings: -72753236
Inventory turnover: 16.572628748514425
Receivables turnover: 9.546884324101375
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -488.90391390118265
FCF margin (%): -34.49073992951356
Revenue growth (%): -1.2435767305877834
Rule of 40 score: -35.73431666010134
Financial ratios for BCHT — quarterly report dated 2025-03-31
Total revenue: 3221011
Gross profit: 1234346
Operating income: -1342953
Net income: -1679220
Capital expenditures: 14153
Operating cash flow: -254335
Depreciation & amortization: 72465
Net tangible assets: -1875145
Owner earnings: -1620908
Buffett classification: The Gruesome
Stock price: 2.5
Shares outstanding: 26305966
Book value: -426832
Market cap (USD): 65764915
Debt to equity: -0.6936616748509953
Current ratio: 0.5485039470944884
Quick ratio: 0.48601879229133443
Interest coverage ratio: -24869.5
COGS to revenue (%): 61.678305351953156
R&D to revenue (%): 12.625725276939445
SG&A to revenue (%): 67.38949354721235
Free cash flow (dilution-adjusted): -329015
Buyback yield (%): 0
Retained earnings: -74432456
Inventory turnover: 3.3548896431767905
Receivables turnover: 2.5198008261100853
Capitalized R&D asset: 406676
ROCI (R&D-adjusted, %): -463.0819835505803
FCF margin (%): -10.214649996538354
Rule of 40 score: -10.214649996538354
Financial ratios for BCHT — quarterly report dated 2025-06-30
Total revenue: 3253911
Gross profit: 968078
Operating income: -1185347
Net income: -1541916
Capital expenditures: 2113
Operating cash flow: -1731412
Depreciation & amortization: 103664
Net tangible assets: -3346483
Owner earnings: -1440365
Buffett classification: The Gruesome
Stock price: 3.4
Shares outstanding: 26305966
Book value: -1949320
Market cap (USD): 89440284.39999999
Debt to equity: -0.1465110910471344
Current ratio: 0.444542146525636
Quick ratio: 0.36374760333866907
COGS to revenue (%): 70.24878676767742
R&D to revenue (%): 13.998078005206658
SG&A to revenue (%): 52.18151326204067
Free cash flow (dilution-adjusted): -1752953
Buyback yield (%): 0
Retained earnings: -75974372
Inventory turnover: 2.751035926147462
Receivables turnover: 1.5061181358431668
Capitalized R&D asset: 727957.92
Rosenberg metric: -0.6547423501755697
FCF margin (%): -53.872186424275284
Revenue growth (%): 1.0214184304244847
Rule of 40 score: -52.8507679938508